Related Experiment Video

Updated: Jul 7, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression

Andre Keren1, Petros Syrris, William J McKenna

  • 1Department of Cardiology, Hadassah University Hospital, Jerusalem, Israel.

Nature Clinical Practice. Cardiovascular Medicine
|January 30, 2008
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is a common inherited heart disorder and a leading cause of sudden death in young individuals. Genetic testing and clinical evaluation are crucial for accurate diagnosis, management, and genetic counseling.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited cardiac disorder.
  • It is a primary cause of sudden cardiac death in young individuals and athletes.
  • HCM presents a heterogeneous clinical phenotype, with mutations in sarcomeric protein genes implicated in ~60% of cases.

Purpose of the Study:

  • To review current knowledge on the genetics and disease mechanisms of HCM.
  • To explore genotype-phenotype correlations in HCM patients.
  • To discuss the implications of genetic testing in clinical practice.

Main Methods:

  • Review of current literature on hypertrophic cardiomyopathy genetics and clinical management.
  • Analysis of genotype-phenotype correlations.
  • Discussion of the role of genetic testing in diagnosis and counseling.

Main Results:

  • Approximately 60% of HCM cases are caused by mutations in sarcomeric contractile-protein genes.
  • Clinical phenocopies, including metabolic and mitochondrial disorders, can mimic HCM but have distinct genetic underpinnings.
  • Accurate diagnosis requires detailed clinical evaluation and mutation analysis.

Conclusions:

  • Distinguishing HCM from its phenocopies is vital as their inheritance, prognosis, and treatment may differ.
  • Genetic testing is essential for accurate diagnosis, enabling genetic counseling, prognostic assessment, and tailored clinical management.
  • Understanding the genetic basis of HCM improves patient care and risk stratification.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genetic Lingo01:11

Genetic Lingo

Overview
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...